Skip to main content

Table 5 Maternal and neonatal complications of participants ≥ 35 years

From: Maternal and neonatal complications after IVF/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study

 

POSEIDON Group 2(n = 971)

POSEIDON Group 4(n = 142)

Control 2 (n = 718)

P value

vanishing twin syndrome

32(3.3)

1(0.7)cd

36(5.0)

0.025

GDM

78(8.0)

20(14.1)cd

54(7.5)

0.032

HDP

39(4.0)

6(4.2)

31(4.3)

0.953

LBW

32(3.9)

2(1.8)

32(5.3)

0.167

Preterm delivery

37(3.8)

6(4.2)

24(3.3)

0.820

Pregnancy loss

 Total pregnancy loss

126(13.0)

28(19.7)d

104(14.5)

0.091

 First trimester pregnancy loss

108(11.1)

26(18.3)cd

87(12.1)

0.049

 Second trimester pregnancy loss

18(1.9)

2(1.4)

17(2.4)

0.758

Induction due to malformation

16(1.6)

4(2.8)

8(1.1)

0.228

Placenta previa

14(1.4)

3(2.1)

10(1.4)

0.716

Fetal macrosomia

97(11.7)

14(12.6)

65(10.8)

0.793

  1. Data are mean ± SD, median (interquartile), or n (%). cp < 0.05, vs. Control 2; dp < 0.05, vs. POSEIDON group 2